These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32212709)

  • 1. Biodegradable Hypericin-Containing Nanoparticles for Necrosis Targeting and Fluorescence Imaging.
    Han X; Taratula O; Taratula O; Xu K; St Lorenz A; Moses A; Jahangiri Y; Yu G; Farsad K
    Mol Pharm; 2020 May; 17(5):1538-1545. PubMed ID: 32212709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation.
    Bao H; Wang N; Chen S; Wang Y; Shao H; Ni Y; Li Y; Liu X; Han X
    Mol Pharm; 2024 Apr; 21(4):1729-1744. PubMed ID: 38449426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
    Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
    Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors.
    Marysael T; Ni Y; Lerut E; de Witte P
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1619-27. PubMed ID: 21858709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multimodal nanoplatform for targeting tumor necrosis.
    Han X; Taratula O; St Lorenz A; Moses AS; Albarqi HA; Jahangiri Y; Wu Q; Xu K; Taratula O; Farsad K
    RSC Adv; 2021 Sep; 11(47):29486-29497. PubMed ID: 35479549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
    Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
    Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
    Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
    Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.
    Kong M; Zhang J; Jiang C; Jiang X; Li Y; Gao M; Yao N; Huang D; Wang X; Fang Z; Liu W; Sun Z; Ni Y
    J Drug Target; 2013 Jul; 21(6):604-10. PubMed ID: 23627568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity.
    Youssef T; Fadel M; Fahmy R; Kassab K
    Pharm Dev Technol; 2012; 17(2):177-86. PubMed ID: 21047275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.
    Jiang B; Wang J; Ni Y; Chen F
    Theranostics; 2013; 3(9):667-76. PubMed ID: 24052807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
    Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
    Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
    Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
    Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles.
    Huntosova V; Nadova Z; Dzurova L; Jakusova V; Sureau F; Miskovsky P
    Photochem Photobiol Sci; 2012 Sep; 11(9):1428-36. PubMed ID: 22729350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
    Li Y; Zhang J; Wang B; Shen Y; Ouahab A
    Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
    Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
    Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
    Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
    J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin.
    Song S; Xiong C; Zhou M; Lu W; Huang Q; Ku G; Zhao J; Flores LG; Ni Y; Li C
    J Nucl Med; 2011 May; 52(5):792-9. PubMed ID: 21498539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells.
    Fadel M; Kassab K; Youssef T
    Lasers Med Sci; 2010 Sep; 25(5):675-83. PubMed ID: 20393766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.
    Ocker L; Adamus A; Hempfling L; Wagner B; Vahdad R; Verburg FA; Luster M; Schurrat T; Bier D; Frank M; Lisec J; Engel N; Seitz G
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101588. PubMed ID: 31704507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.
    de Morais FAP; Gonçalves RS; Vilsinski BH; Lazarin-Bidóia D; Balbinot RB; Tsubone TM; Brunaldi K; Nakamura CV; Hioka N; Caetano W
    Photochem Photobiol Sci; 2020 May; 19(5):620-630. PubMed ID: 32248218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.